AstraZeneca Pharma India Limited — Important, 22-07-2025: Updates

AstraZeneca Pharma India has filed its Business Responsibility and Sustainability Report for FY2024-25. The company reported a turnover of `1,716.29 Cr, with exports contributing `109.69 Cr (6.4%). Permanent employee attrition rose to 24.19% due to a Mutual Separation Programme. A significant concern is the sharp increase in employee Lost Time Injury Frequency Rate (LTIFR) to 1,851.91, indicating deteriorating workplace safety. Accounts payable days nearly doubled to 138. While environmental intensities for energy and water improved, total GHG emissions increased, attributed to an expanded reporting scope. The company also reported 9 data breaches, though without customer PII impact.